These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22444598)

  • 1. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection.
    Fu X; Wan S; Hann HW; Myers RE; Hann RS; Au J; Chen B; Xing J; Yang H
    Eur J Cancer; 2012 May; 48(7):1014-22. PubMed ID: 22444598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.
    Wan S; Hann HW; Ye Z; Hann RS; Lai Y; Wang C; Li L; Myers RE; Li B; Xing J; Yang H
    Carcinogenesis; 2017 Apr; 38(4):439-446. PubMed ID: 28334112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: a nested case-control analysis.
    Wan S; Hann HW; Myers RE; Fu X; Hann RS; Kim SH; Tang H; Xing J; Yang H
    Liver Int; 2012 Sep; 32(8):1233-41. PubMed ID: 22471856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
    Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
    Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case-control analysis.
    Liu J; Yang Y; Zhang H; Zhao S; Liu H; Ge N; Yang H; Xing JL; Chen Z
    Cancer; 2011 Sep; 117(18):4247-56. PubMed ID: 21387275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection.
    Li L; Hann HW; Wan S; Hann RS; Wang C; Lai Y; Ye X; Evans A; Myers RE; Ye Z; Li B; Xing J; Yang H
    Sci Rep; 2016 Apr; 6():23992. PubMed ID: 27063412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Hann HW; Wan S; Lai Y; Hann RS; Myers RE; Patel F; Zhang K; Ye Z; Wang C; Yang H
    J Gastroenterol Hepatol; 2015 Jan; 30(1):131-138. PubMed ID: 24995497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization.
    Liu HQ; An JZ; Liu J; Yang YF; Zhang HX; Zhao BY; Li JB; Yang HS; Chen ZN; Xing JL
    Carcinogenesis; 2012 May; 33(5):1040-5. PubMed ID: 22318909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of hepatitis B core-related antigen in chronic hepatitis B and hepatocellular carcinoma patients.
    Chen S; Jia J; Gao Y; Li H; Fang M; Feng H; Guan W; Ji J; Gao Z; Gao C
    Clin Chim Acta; 2018 Nov; 486():237-244. PubMed ID: 30025756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aflatoxin B
    Chu YJ; Yang HI; Wu HC; Liu J; Wang LY; Lu SN; Lee MH; Jen CL; You SL; Santella RM; Chen CJ
    Int J Cancer; 2017 Aug; 141(4):711-720. PubMed ID: 28509392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
    Li Q; Yu CH; Yu JH; Liu L; Xie SS; Li WW; Yang X; Fan WB; Gai ZT; Chen SJ; Kato N
    PLoS One; 2012; 7(1):e29928. PubMed ID: 22235351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
    Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
    Kim GA; Han S; Choi GH; Choi J; Lim YS
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
    Li L; Guo Z; Wang J; Mao Y; Gao Q
    Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.